Related references
Note: Only part of the references are listed.Identification of Novel Serological Autoantibodies in Takayasu Arteritis Patients Using HuProt Arrays
Xiaoting Wen et al.
MOLECULAR & CELLULAR PROTEOMICS (2021)
Potential Role of Macrophage Phenotypes and CCL2 in the Pathogenesis of Takayasu Arteritis
Xiufang Kong et al.
FRONTIERS IN IMMUNOLOGY (2021)
Elevated chemokines concentration is associated with disease activity in Takayasu arteritis
Hui Dong et al.
CYTOKINE (2021)
Serum C1q concentration is associated with disease activity in Chinese Takayasu arteritis patients: A case-control study
Si Chen et al.
HEALTH SCIENCE REPORTS (2021)
Serum complement 3 is a potential biomarker for assessing disease activity in Takayasu arteritis
Rongyi Chen et al.
ARTHRITIS RESEARCH & THERAPY (2021)
Clinical usefulness of longitudinal IL-6 monitoring in a patient with Takayasu aortitis receiving tocilizumab
Naoto Sakumura et al.
RHEUMATOLOGY (2020)
Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study
Yoshikazu Nakaoka et al.
RHEUMATOLOGY (2020)
Association between the antineutrophil cytoplasmic antibody and late coronary arterial occlusive disease in patients with Takayasu arteritis
Hyeok Choi et al.
JOURNAL OF CARDIOLOGY (2020)
Identification of two major autoantigens negatively regulating endothelial activation in Takayasu arteritis
Tomoyuki Mutoh et al.
NATURE COMMUNICATIONS (2020)
Performance of the PET vascular activity score (PETVAS) for qualitative and quantitative assessment of inflammatory activity in Takayasu's arteritis patients
Fei Kang et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasu's arteritis patients
Jing Li et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Radiology and biomarkers in assessing disease activity in Takayasu arteritis
Ying Sun et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2019)
PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases
Giuseppe A. Ramirez et al.
FRONTIERS IN IMMUNOLOGY (2019)
Novel Biomarkers for the Precisive Diagnosis and Activity Classification of Takayasu Arteritis
Xiao Cui et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2019)
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)
Yoshikazu Nakaoka et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
18F-Fluorodeoxyglucose positron emission tomography and serum cytokines and matrix metalloproteinases in the assessment of disease activity in Takayasu's arteritis
Anne E. D. Arraes et al.
REVISTA BRASILEIRA DE REUMATOLOGIA (2016)
Association of ferritin antibodies with Takayasu arteritis
K. Grosse et al.
CLINICAL RHEUMATOLOGY (2014)
Acknowledged Signatures of Matrix Metalloproteinases in Takayasu's Arteritis
Gang Wu et al.
BIOMED RESEARCH INTERNATIONAL (2014)
New treatment strategies in large-vessel vasculitis
Sebastian Unizony et al.
CURRENT OPINION IN RHEUMATOLOGY (2013)
Pathology of Takayasu arteritis: A brief review
Pradeep Vaideeswar et al.
ANNALS OF PEDIATRIC CARDIOLOGY (2013)
Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab
Bimba F. Hoyer et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
MMP-9 and IL-6 are potential biomarkers for disease activity in Takayasu's arteritis
Ying Sun et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
Takayasu Arteritis: Diagnosis, Treatment and Prognosis
Dan Wen et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2012)
Physiology and pathophysiology of matrix metalloproteases
T. Klein et al.
AMINO ACIDS (2011)
Pathogenesis of Takayasu's arteritis: A 2011 update
Laurent Arnaud et al.
AUTOIMMUNITY REVIEWS (2011)
Sensitive Assessment of Activity of Takayasu's Arteritis by Pentraxin3, a New Biomarker
Takashi Ishihara et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Circulating B lymphocytes producing autoantibodies to endothelial cells play a role in the pathogenesis of Takayasu arteritis
Haitao Wang et al.
JOURNAL OF VASCULAR SURGERY (2011)
Soluble RAGE-Modulating Drugs: State-of-the-Art and Future Perspectives for Targeting Vascular Inflammation
Niccolo Lanati et al.
CURRENT VASCULAR PHARMACOLOGY (2010)
Implication of oxidative stress and its correlation with activity of matrix metalloproteinases in patients with Takayasu's arteritis disease
Nitin Mahajan et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Vasculitis and infections: Contribution to the issue of autoimmunity reviews devoted to autoimmunity and infection
Cees G. M. Kallenberg et al.
AUTOIMMUNITY REVIEWS (2008)
Role of C-C chemokines in Takayasu's arteritis disease
Veena Dhawan et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2006)
Takayasu's arteritis: An update on physiopathology
Laurent Arnaud et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2006)
Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis
MC Park et al.
RHEUMATOLOGY (2006)
P-selectin expression, but not GPIIb/IIIa activation, is enhanced in the inflammatory stage of Takayasu's arteritis
N Kasuya et al.
CIRCULATION JOURNAL (2006)
The P-selectin, tissue factor, coagulation triad
J Polgar et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Cytokine mRNA repertoire of peripheral blood mononuclear cells in Takayasu's arteritis
NK Tripathy et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Matrix metalloproteinases as novel disease markers in Takayasu arteritis
A Matsuyama et al.
CIRCULATION (2003)
Share Paper
